Enanta Pharmaceuticals Inc - ENTA

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 12/10/2025 10:05:24 PM
EDGAR CIK 0001177648

Buy Breakdown

Total $256,050

Sell Breakdown

Total $183,167

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
12/05/2025
12/05/2025
Capps Kathleen S.
Executive Director of Accounting, Controller (Prin
Officer
Sell
-323 @ $14.23
($4,596.29)
 8,377 (-3.71%) Direct
12/05/2025
12/05/2025
Kieffer Tara Lynn
Chief Product Strategy Officer
Officer
Sell
-2,106 @ $14.23
($29,968.38)
 30,620 (-6.44%) Direct
12/05/2025
12/05/2025
Luly Jay R.
President and CEO
CEO Director
Sell
-4,743 @ $14.23
($67,492.89)
 858,026 (-0.55%) Direct
12/05/2025
12/05/2025
Luu Brendan
Chief Business Officer
Officer
Sell
-1,394 @ $14.23
($19,836.62)
 38,329 (-3.51%) Direct
12/05/2025
12/05/2025
Or Yat Sun
Chief Scientific Officer
Officer
Sell
-2,390 @ $14.23
($34,009.70)
 371,392 (-0.64%) Direct
12/05/2025
12/05/2025
Rottinghaus Scott T.
Chief Medical Officer
Officer
Sell
-798 @ $14.23
($11,355.54)
 21,792 (-3.53%) Direct
12/05/2025
12/05/2025
Trout Harry R. Iii
Vice President, Finance (Principal Financial Offic
Officer
Sell
-542 @ $14.23
($7,712.66)
 16,348 (-3.21%) Direct
12/02/2025
12/03/2025
Capps Kathleen S.
Executive Director of Accounting, Controller (Prin
Officer
Sell
-207 @ $13.96
($2,889.72)
 8,700 (-2.32%) Direct
12/02/2025
12/03/2025
Trout Harry R. Iii
Vice President, Finance (Principal Financial Offic
Officer
Sell
-380 @ $13.96
($5,304.80)
 16,890 (-2.20%) Direct
02/12/2025
02/12/2025
Luly Jay R.
President and CEO
CEO Director
Buy
45,000 @ $5.69
$256,050.00
 846,638 (5.61%) Direct